4Huseton WJ. A cast-benefit analysis of testing for influenza A in high-risk adults. Ann-Fanv-Med 2004,2:33-40.
5Lowe-J-A 3^rd. Structure-activity relationships of potent, Selective inhibitors of neuronal nitric oxide synthase based on the 6-phenyl-2-aminopyrldine structure. J-Med-Chem 2004,11:47,1576-1586.
9Derion T. Considerations for the phanning and conduct of reproducibility studies of in vitro diagnostic tests for infectious agents. Biotech-Annu-Rev 2003,9: 249-258.
2Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase[J].Science,1990,249(4968):505-510
3Ellington AD, Szostak JW. In vitro selectivon of RNA molecules that bind specific ligands[J]. Nature, 1990, 346(6287) :818 - 822.
4Hicke BJ, stephens AW. Escort aptamers:a delivery service for diagnosis and therapy[J]. J Clin Invest, 2000, 106(8):923-928.
6Faria M, Ulrich H. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy:accomplishments and limitaions[J].Curr Cancer Drug Targets,2002,2(4):355-368
7Joshi P, Prasad VR. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX(systematic evolution of ligands by exponential enrichment)[J].J Virol,2002,76(13):6545-6557
8Andreola ML, Pileur F, Calmels C, et al. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity[J].Biochemistry,2001,40(34):10087-10094
9Bock LC, Griffin LC, Latham JA,et al. Selection of single-swanded DNA molecules that bind and inhibit human thrombin[J]. Nature, 1992, 355(6360) :564- 566.
10Rusconi CP,Yeh A,Lyerly HK,et al.Blocking the initiation of coagulation by RNA aptamers to factor Ⅶa[J].Thromb Haemost,2000,84(5):841-848
